Indications to begin antiviral therapy in patients with chronic HBV without concern for significant hepatic fibrosis 
are: 1) ALT >2 times the upper limit of normal and HBV DNA >2,000 IU/mL for HBeAg negative patients, 
or 2) ALT >2 times the upper limit of normal and HBV DNA >20,000 IU/mL for HBeAg positive patients. 


immune tolerant
normal ALT x 2, and HBV DNA > 10,000,000 in HBeAg +
> 40 yo with sig inflammation => grade 2 or fibrosis => f2 canc sondier life long tx
< 40 yo old no tx, unless desired
